Related Experiment Video
Updated: Aug 14, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Current issues regarding the pathobiology of asbestosis: a chronologic perspective
1Department of Pathology, Georgetown University School of Medicine, Washington, DC 20007.
Journal of Thoracic Imaging
|October 1, 1988
Summary
Asbestosis, a lung disease from asbestos inhalation, involves alveolar macrophages and epithelial injury. Early histologic signs appear within months, but radiological detection is delayed by a decade or more.
Area of Science:
- Pulmonary Medicine
- Occupational Health
Background:
- Asbestosis is a serious lung condition caused by inhaling asbestos fibers.
- Alveolar macrophages play a key role in the development of asbestosis.
- Injury to the alveolar epithelium may also contribute to the disease's pathogenesis.
Purpose of the Study:
- To explore the pathogenesis of asbestosis.
- To investigate the role of inflammatory mediators in asbestos-induced pulmonary fibrosis.
- To examine the diagnostic delay between histological and radiological detection of asbestosis.
Main Methods:
- Review of existing evidence on asbestosis pathogenesis.
- Analysis of histological findings in asbestos-exposed individuals.
- Comparison of the timeline for histological versus radiological detection of disease.
Main Results:
- Asbestos fiber inhalation leads to alveolar macrophage activation and potential epithelial injury.
- Persistent release of inflammatory mediators at asbestos deposition sites contributes to pulmonary fibrosis.
- Histological changes are detectable within months, while radiological signs require a latency period of at least a decade.
Conclusions:
- Alveolar macrophages and epithelial injury are central to asbestosis development.
- A significant diagnostic delay exists between early histological detection and later radiological confirmation of asbestosis.
- Understanding these mechanisms is crucial for timely diagnosis and management of asbestos-related lung disease.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...